"As Required" Oral Sildenafil in Raynaud's Phenomenon

NCT02050360 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Raynaud's Phenomenon

Interventions

DRUG: Sildenafil 40 mg
DRUG: Sildenafil 80 mg
DRUG: Placebo

Sponsor

University Hospital, Grenoble